Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

E Jonasch, CL Walker, WK Rathmell - Nature Reviews Nephrology, 2021 - nature.com
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …

Pheochromocytoma and paraganglioma

HPH Neumann, WF Young Jr… - New England journal of …, 2019 - Mass Medical Soc
Pheochromocytoma and Paraganglioma Pheochromocytoma and paraganglioma are
related tumors that differ mainly in location; pheochromocytomas are adrenal, and …

[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

J Jin, Y Xie, JS Zhang, JQ Wang, SJ Dai, W He… - Drug Resistance …, 2023 - Elsevier
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …

Hypoxic control of metastasis

EB Rankin, AJ Giaccia - Science, 2016 - science.org
Metastatic disease is the leading cause of cancer-related deaths and involves critical
interactions between tumor cells and the microenvironment. Hypoxia is a potent …

[HTML][HTML] Multiple primary tumours: challenges and approaches, a review

A Vogt, S Schmid, K Heinimann, H Frick, C Herrmann… - ESMO open, 2017 - Elsevier
When in a patient more than one tumour in the same or a different organ is diagnosed,
multiple primary tumours may be present. For epidemiological studies, different definitions of …

FDA approval summary: belzutifan for von Hippel-Lindau disease–associated tumors

J Fallah, MH Brave, C Weinstock, GU Mehta… - Clinical Cancer …, 2022 - AACR
Abstract On August 13, 2021, the FDA approved belzutifan (WELIREG, Merck), a first-in-
class hypoxia-inducible factor (HIF) inhibitor for adult patients with von Hippel-Lindau (VHL) …

Regulation of erythropoiesis by hypoxia-inducible factors

VH Haase - Blood reviews, 2013 - Elsevier
A classic physiologic response to systemic hypoxia is the increase in red blood cell
production. Hypoxia-inducible factors (HIFs) orchestrate this response by inducing cell-type …

Advances in the diagnosis and management of well-differentiated neuroendocrine neoplasms

J Hofland, G Kaltsas, WW de Herder - Endocrine Reviews, 2020 - academic.oup.com
Neuroendocrine neoplasms constitute a diverse group of tumors that derive from the
sensory and secretory neuroendocrine cells and predominantly arise within the pulmonary …

[HTML][HTML] A review of Von Hippel-Lindau syndrome

N Varshney, AA Kebede… - Journal of Kidney …, 2017 - ncbi.nlm.nih.gov
Abstract Von Hippel-Lindau syndrome (VHL) is a familial neoplastic condition seen in
approximately 1 in 36,000 live births. It is caused by germline mutations of the tumor …

Genetics and epigenetics of gastroenteropancreatic neuroendocrine neoplasms

A Mafficini, A Scarpa - Endocrine reviews, 2019 - academic.oup.com
Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are heterogeneous
regarding site of origin, biological behavior, and malignant potential. There has been a rapid …